◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksC › CGC

Canopy Growth Corporation (CGC) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-06

Canopy Growth Corporation (CGC) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Smiths Falls, Canada with about 1,128 employees. Its market capitalization is roughly $463 million. In the fiscal year ended 2026-03-31, CGC reported C$285M in revenue and (C$263M) in net income.

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.

Interactive charts & full statements → Open the CGC valuation workbench →

CGC Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-312022-03-31
Total RevenueC$285MC$269MC$297MC$333M
Gross ProfitC$70MC$80MC$81M(C$64M)
Operating Income (EBIT)(C$73M)(C$66M)(C$163M)(C$396M)
Net Income(C$263M)(C$509M)(C$694M)(C$3.3B)

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CGC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total RevenueC$81MC$71MC$74MC$67MC$72M
Gross ProfitC$22MC$8MC$22MC$22MC$18M
Operating Income (EBIT)(C$18M)(C$28M)(C$13M)(C$15M)(C$18M)
Net Income(C$15M)(C$157M)(C$63M)(C$2M)(C$45M)

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CGC Free Cash Flow History

CGC Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-312022-03-31
Total AssetsC$1.1BC$918MC$1.3BC$2.4B
Total LiabilitiesC$421MC$439MC$900MC$1.7B

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CGC viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← CGBLAll “C” companiesCGCB →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.